Vasculature seeps into the hypoxic tumor mass in the next phase when TME cells release proangiogenic substances, such as different matrix metalloproteinases (MMPs), growth factors, cytokines, TGF-β, and vascular endothelial growth factor (VEGF) [40,56]. Here, VEGFA is linked to neoplasm.